Artiva Biotherapeutics Inc
NASDAQ:ARTV

Watchlist Manager
Artiva Biotherapeutics Inc Logo
Artiva Biotherapeutics Inc
NASDAQ:ARTV
Watchlist
Price: 4.18 USD -5.64% Market Closed
Market Cap: 53.7m USD

Wall Street
Price Targets

ARTV Price Targets Summary
Artiva Biotherapeutics Inc

Wall Street analysts forecast ARTV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARTV is 17.34 USD with a low forecast of 10.1 USD and a high forecast of 24.15 USD.

Lowest
Price Target
10.1 USD
142% Upside
Average
Price Target
17.34 USD
315% Upside
Highest
Price Target
24.15 USD
478% Upside
Artiva Biotherapeutics Inc Competitors:
Price Targets
4587
PeptiDream Inc
94% Upside
603087
Gan & Lee Pharmaceuticals
4% Downside
NTRA
Natera Inc
6% Upside
FOLD
Amicus Therapeutics Inc
14% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
60% Upside
RCKT
Rocket Pharmaceuticals Inc
124% Upside
PBYI
Puma Biotechnology Inc
21% Downside
302440
SK Bioscience Co Ltd
19% Downside

Revenue
Forecast

Revenue Estimate
Artiva Biotherapeutics Inc

For the last 2 years the compound annual growth rate for Artiva Biotherapeutics Inc's revenue is -77%. The projected CAGR for the next 4 years is 105%.

-77%
Past Growth
105%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Artiva Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Artiva Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARTV's stock price target?
Price Target
17.34 USD

According to Wall Street analysts, the average 1-year price target for ARTV is 17.34 USD with a low forecast of 10.1 USD and a high forecast of 24.15 USD.

What is Artiva Biotherapeutics Inc's Revenue forecast?
Projected CAGR
105%

For the last 2 years the compound annual growth rate for Artiva Biotherapeutics Inc's revenue is -77%. The projected CAGR for the next 4 years is 105%.

Back to Top